PROFUND ADVISORS LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1129919 BETHESDA, MD

Position in CRNX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$355,789

+$64,685 QoQ

Shares Held

9,508

+18.6% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#162

of 264 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $162,985,629 across 169 Biotechnology names. CRNX ranks #119 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535
8	KYMR	Kymera Therapeutics, Inc.	18,455	$2,116,234

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$355,789	9,508	+18.6%	Shares	Sole	2026-08-11
2026-03-31	$291,104	8,015	+15.3%	Shares	Sole	2026-04-27
2025-12-31	$323,522	6,950	-31.1%	Shares	Sole	2026-02-06
2025-09-30	$420,290	10,091	-48.8%	Shares	Sole	2025-11-06
2025-06-30	$566,485	19,697	-10.1%	Shares	Sole	2025-08-07
2025-03-31	$735,096	21,917	+29.8%	Shares	Sole	2025-05-08
2024-12-31	$863,330	16,885	-15.8%	Shares	Sole	2025-02-14
2024-09-30	$1,025,117	20,061	-6.5%	Shares	Sole	2024-11-14
2024-06-30	$961,506	21,467	-37.4%	Shares	Sole	2024-08-13
2024-03-31	$1,604,787	34,283	-14.6%	Shares	Sole	2024-05-08
2023-12-31	$1,427,967	40,134	+18.6%	Shares	Sole	2024-02-14
2023-09-30	$1,005,985	33,826	+32.2%	Shares	Sole	2023-11-13
2023-06-30	$461,239	25,596	+4.9%	Shares	Sole	2023-08-10
2023-03-31	$391,912	24,403	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.